OAR 855-019-0265
Administration of Drugs

(1)

In accordance with ORS 689.655 (Power to administer drugs and devices), a pharmacist may administer a drug or device as specified in this rule.

(2)

A pharmacist who administers a drug or device must:

(a)

Observe, monitor, report, and otherwise take appropriate action regarding desired effect, side effect, interaction, and contraindication associated with administering the drug or device; and

(b)

Ensure a record is kept for three years of such activities. This record shall include but is not limited to:

(A)

Patient identifier;

(B)

Drug or device and strength;

(C)

Route and site of administration;

(D)

Date and time of administration;

(E)

Pharmacist identifier.

(3)

The pharmacist must be acting:

(a)

Under the direction of or pursuant to a lawful prescription or order issued by a licensed practitioner acting within the scope of the practitioner’s practice or;

(b)

In accordance with a written protocol or collaborative drug therapy agreement with a licensed practitioner.

(4)

The pharmacist must be able to document that they have received training on the drug or device to be administered and the route of administration. Such training may include a program approved by the ACPE, curriculum based programs from an ACPE-accredited college, state or local health department programs, training by an appropriately qualified practitioner, or programs approved by the Board.

(5)

The pharmacist may administer a drug or device in conjunction with training the patient or the patient’s caregiver how to administer or self-administer the drug or device.

Source: Rule 855-019-0265 — Administration of Drugs, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=855-019-0265.

855‑019‑0100
Application 855‑019‑0110
Definitions 855‑019‑0120
Licensure 855‑019‑0122
Renewal of Licensure as a Pharmacist 855‑019‑0123
Liability Limitations for Volunteers 855‑019‑0125
Coaching from Board and Staff 855‑019‑0130
Licensure by Reciprocity 855‑019‑0140
NAPLEX Score Transfer 855‑019‑0150
Foreign Pharmacy Graduates 855‑019‑0160
Nuclear Pharmacists 855‑019‑0170
Reinstatement of License 855‑019‑0171
Reinstatement of a Revoked or Surrendered License 855‑019‑0200
General Responsibilities of a Pharmacist 855‑019‑0205
Duty to Report 855‑019‑0210
Duties of the Pharmacist Receiving a Prescription 855‑019‑0220
Drug Utilization Review (DUR) 855‑019‑0230
Counseling 855‑019‑0240
Consulting Pharmacist Practice 855‑019‑0250
Medication Therapy Management 855‑019‑0260
Collaborative Drug Therapy Management 855‑019‑0265
Administration of Drugs 855‑019‑0270
Immunization Qualifications 855‑019‑0280
Immunization Protocols, Policies and Procedures 855‑019‑0290
Immunization Record Keeping and Reporting 855‑019‑0300
Duties of a Pharmacist-in-Charge 855‑019‑0310
Grounds for Discipline 855‑019‑0400
Contraceptives - Purpose 855‑019‑0405
Contraceptives - Definitions 855‑019‑0410
Prescriptive Practice Consultation 855‑019‑0415
Contraceptive - Training Program 855‑019‑0425
Contraceptive - Procedural Mandates 855‑019‑0430
Contraceptive - Prohibited Practices 855‑019‑0435
Contraceptive - Records 855‑019‑0460
Naloxone - Delivery of Care and Prescribing 855‑019‑0470
Emergency Insulin
Last Updated

Jun. 8, 2021

Rule 855-019-0265’s source at or​.us